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Abstract
Background:  In this study, we investigated the effect of genetic background on expression
profiles. We analysed the transcriptome of mouse hindlimb muscle of five frequently used mouse
inbred strains using spotted oligonucleotide microarrays.
Results: Through ANOVA analysis with a false discovery rate of 10%, we show that 1.4% of the
analysed genes is significantly differentially expressed between these mouse strains. Differential
expression of several of these genes has been confirmed by quantitative RT-PCR. The number of
genes affected by genetic background is approximately ten-fold lower than the number of
differentially expressed genes caused by a dystrophic genetic defect.
Conclusions: We conclude that evaluation of the effect of background on gene expression
profiles in the tissue under study is an effective and sensible approach when comparing expression
patterns in animal models with heterogeneous genetic backgrounds. Genes affected by the genetic
background can be excluded in subsequent analyses of the disease-related changes in expression
profiles. This is often a more effective strategy than backcrossing and inbreeding to obtain isogenic
backgrounds.
Background
Due to their isogenicity, inbred mouse strains demon-
strate low biological variability within each strain[1,2].
Genetic variation between inbred strains is considerable
and has recently been characterized in detail using single
nucleotide polymorphisms[3]. Differences in genetic
background between strains affect the gene expression lev-
els of a subset of genes, which probably explains pheno-
typic differences. Indeed, several reports have been
published in which gene expression profiles have been
used as QTLs in genetic mapping studies to identify com-
plex traits [4-6].
From literature [7-9], it appears that the subset of genes
for which expression is significantly affected by genetic
background is small. However, this has never been related
to the extent of gene expression changes observed due to
disease-causing mutations. We are studying differential
gene expression between affected and healthy muscle in a
range of murine models for neuromuscular disorders with
Published: 18 August 2004
BMC Genomics 2004, 5:57 doi:10.1186/1471-2164-5-57
Received: 13 May 2004
Accepted: 18 August 2004
This article is available from: http://www.biomedcentral.com/1471-2164/5/57
© 2004 Turk et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2004, 5:57 http://www.biomedcentral.com/1471-2164/5/57
Page 2 of 8
(page number not for citation purposes)
different genetic backgrounds (Turk et al., manuscript in
preparation). We, therefore, determined gene expression
levels in hindlimb muscles from five frequently used
wildtype mouse inbred strains, and compared these to the
differential gene expression levels in affected muscle tis-
sue from a mouse model (mdx) for Duchenne muscular
dystrophy with healthy muscle tissue. Both the number of
differentially expressed genes between strains as well as
the fold-change levels are lower when compared to the
differences found in affected versus healthy muscle tissue.
Results
Gene expression levels in hindlimb muscle tissue from
five different inbred strains (CBA, BALB, BL6, DBA, and
BL10) were determined. Total RNA from two individuals
per strain was isolated, reversed transcribed, and subse-
quently labelled according to a recently developed proto-
col (adapted from Xiang et al., 2002), which requires an
input of only 1 µg total RNA. Labelled cDNA was hybrid-
ised to murine microarrays containing 7,776 65-mer oli-
gonucleotides spotted in duplicate.
Significance levels (p-values) between the five mouse
inbred strains were calculated using analysis of vari-
ance[10]. Significance levels among two individual mice
within each strain were determined using a hierarchical t-
test providing higher statistical power than conservative
methods for low (2–4) replicate numbers[11]. The higher
power is yielded by borrowing information across genes
to produce a better expression variance estimator. The
gain in power is reported via an increase in the degrees of
freedom associated with the t-test. Differentially expressed
genes for both computations were selected by controlling
the false discovery rate (FDR), as suggested by Benjamini
and Hochberg (1995), rather than using pre-defined cut-
offs for p-values or corrections for multiple testing. The
FDR represents an expectation of the proportion of false
positives among the selected differentially expressed
genes, which increases dramatically during multiple test-
ing, inherent in microarray experiments[12].
Using an FDR of 10% we selected 88 out of 6144 (1.4%)
expressed genes that are differentially expressed between
strains (Fig. 1). A lower number of differentially expressed
genes was found in the analysis of variation within strains
with identical FDRs of 10% (Table 1). Results with other
FDR levels are available online as additional file. Correla-
tion between gene expression levels of the two samples
from each strain was high (Pearson correlation coefficient
ranging from 0.87 to 0.95), also indicating low internal
variation (Table 1). A considerable amount of differen-
tially expressed genes (718 genes) were selected when pre-
defined cut-off values (p < 0.05) were used to determine
the differential gene expression between strains. However,
adjusted FDR levels indicated a proportion of false posi-
tives equal to 42%. On the other hand, adjusting for mul-
tiple testing using Bonferroni correction proved to be too
stringent, leaving no or few differentially expressed genes.
Controlling the FDR, therefore, appears to be an optimal
method for both selecting differential gene expression and
simultaneously determining the validity of the experi-
mental outcome.
To put the influence of differential gene expression due to
genetic background in perspective, we studied gene
expression between affected and healthy tissue from hind-
limb muscle derived from mdx mice, and from control
mice with identical genetic backgrounds. Selection with
an FDR of 10% resulted in 1298 differentially expressed
genes. Differential gene expression between the two most
divergent mouse inbred strains (BL6 and CBA, data not
shown) was determined to allow a direct comparison with
identical statistical methods. Selection with an FDR of
10% showed an approximately ten-fold decrease in the
number of differentially expressed genes (126). Absolute
fold changes were calculated and subsequently a compar-
ison of the distribution was made (Fig. 2). Median gene
expression levels are equal between affected/control and
inbred/inbred. However, the number of large fold
changes (>3) between affected/healthy (221) is much
higher than between inbred/inbred (7), consistent with
low contribution of differential expression due to genetic
background.
Although overall expression levels are similar between
strains, a relatively high number of differentially
expressed genes was due to deviating gene expression lev-
els in BL6. We performed quantitative real-time RT-PCR
(qPCR) on five genes to verify our microarray data. Two
genes myomesin 1 and tropomodulin 1, which were 2.2-
fold and 1.8-fold lower expressed in BL6 compared to the
other strains on our microarrays, were also found to be
lower expressed (2.0-fold and 2.2-fold respectively) in our
qPCR assay (Fig. 3). Three other genes (dysferlin, cystatin
B, and thrombospondin 4) showed no differential expres-
sion between any strains.
Discussion
This study shows that variation in overall gene expression
levels between mouse inbred strains is relatively low in
hindlimb muscle tissue. This is particularly evident when
the number of differentially expressed genes between two
mouse inbred strains (C57 vs. Bl6, 126 genes with 7 genes
having a fold-change > 3) is compared to that between
diseased and healthy muscle tissue (mdx  vs. wild-type,
1298 genes with 221 genes having a fold-change >3).
Therefore, the use of mice with deviating genetic back-
ground may be justified in disease-related studies. Alter-
natively, strain-dependent gene expression differencesBMC Genomics 2004, 5:57 http://www.biomedcentral.com/1471-2164/5/57
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Differentially expressed genes between mouse inbred strains Figure 1
Differentially expressed genes between mouse inbred strains Relative expression levels of differentially expressed genes 
between mouse inbred strains are depicted in colour as relative intensity levels. Shown for each gene are GenBank accession 
number, description, functional annotation according to Gene Ontology, and UniGene cluster IDs. Relative expression levels 
are calculated by subtracting the average intensity value per gene from the strain-dependent intensity values. Differential 
expression was determined by selecting p-values from analysis of variance based on a false discovery rate of 10%.BMC Genomics 2004, 5:57 http://www.biomedcentral.com/1471-2164/5/57
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Table 1: Number of differentially expressed genes using several cut-off strategies
Between strains Within strains
MA-ANOVA Hierarchical t-test
CBA BL10 BL6 DBA BALB
Correlation 0.95 0.95 0.87 0.87 0.92
Naive (p < 0.05) 718 737 610 963 1043 483
B o n f e r r o n i 024103
FDR 10% 88 2 4 14 0 16
Correlation between two individuals per strain was calculated using Pearson's correlation coefficient. Significance levels (p-values) between strains 
were calculated with MA-ANOVA, and within strains using the hierarchical t-test. Differential gene expression was determined by selecting genes 
with p-values lower than a specified threshold. Thresholds were selected using three different strategies; naive, Bonferroni corrected, and False 
Discovery Rate (10%), and resulted in different numbers of significantly differentially expressed genes.
Effect of different genetic background on differential gene expression Figure 2
Effect of different genetic background on differential gene expression The distribution of absolute fold changes of differentially 
expressed genes (n = 1298) between affected (mdx) and healthy (WT) muscle were compared to the distribution of absolute 
fold changes of differentially expressed genes (n = 126) between two mouse inbred strains (CBA and BL6). Selections were 
based on a FDR of 10%.
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may be evaluated in the initial study phase of gene target-
ing experiments, although the effect of hybrid back-
grounds is difficult to assess.
Gene expression studies in the brain revealed that approx-
imately 1% of expressed genes differ between two mouse
strains[8]. Application of alternative statistical methods,
similar to those used in our study, on this dataset resulted
in an increase in the number of differentially expressed
genes (approx. 3%) between the two mouse strains[7],
demonstrating that the number of differentially expressed
genes is highly dependent on the statistical criteria used. A
similar number of differentially expressed genes was
found in a comparison of hippocampal gene expression
between 8 different mouse strains[9]. The results of our
study in muscle tissue demonstrated that approximately
1.4% of the expressed genes show differential expression
between mouse strains. Based on these results, strain dif-
ferences in gene expression seem to have a similar magni-
tude across different tissues.
Genomic variability could be correlated with high levels
of single nucleotide polymorphisms (SNPs) occurring in
specific blocks between mouse inbred strains. The pres-
ence of cis-acting (single nucleotide) polymorphisms may
be associated with regulatory variation affecting gene
expression levels. It was estimated that probably a consist-
ent amount (up to 6%) of the roughly estimated 35,000
mouse genes contain such functional regulatory vari-
ants[13]. We investigated if differentially expressed genes
were localized in blocks with high genomic variability,
but our number of differentially expressed genes was too
low to obtain statistically significant answers (data not
shown).
Validation of BL6-dependent gene expression with qPCR Figure 3
Validation of BL6-dependent gene expression with qPCR Relative gene expression levels between mouse inbred strains of tro-
pomodulin 1 (Tmod1) and myomesin 1 (Myom1) as determined by quantitative RT-PCR. Significantly lower expression (p < 
0.01, marked by *) for both genes was shown in BL6 compared to other strains.
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This study suggests an additional method for phenotyping
mouse inbred strains and provides a list of genes with sig-
nificant differential expression based upon false discovery
rate selection. Although overall gene expression profiles
are highly similar, most significant differences are deter-
mined by low gene expression levels of BL6 compared to
the other strains. A large proportion of these BL6-specific
genes function as structural muscle proteins (i.e. nebulin,
alpha-actinin 2, myomesin 1 and radixin). To date, how-
ever, no major differences in muscle physiology in BL6-
mice have been described which can be attributed to these
reduced gene expression levels.
Perfectly isogenic backgrounds are sometimes difficult to
obtain. This explorative study demonstrates that the effect
of genetic background on muscle expression profiles is
significant but rather limited compared to other effects,
e.g. the dystrophic genetic defect (mdx) we study. As such,
the genetic background will only marginally interfere with
data analysis. Determination of gene expression profiles
between mouse strains enables flagging a modest number
of differentially expressed genes, and is an efficient and
sensible approach to circumvent tedious backcrossings,
necessary to obtain isogenic animals.
Methods
Mouse breeding, tissue preparation and total RNA 
isolation
We obtained CBA/CaOlaHsd (CBA), BALB/cOlaHsd
(BALB), C57Bl/6JOlaHsd (BL6), DBA/2OlaHsd (DBA),
and C57Bl/10ScSnOlaHsd (BL10) mice from Harland
Laboratories, and C57Bl/10ScSn-Dmdmdx/J  (mdx) mice
from Jackson Laboratory at the age of 6 weeks. Mice were
kept under standard conditions and were sacrificed by cer-
vical dislocation when 8 weeks old. Hindlimb muscles
(m. quadriceps femoris) were dissected and promptly
snap-frozen in isopentane at -80°C. Total RNA was pre-
pared by disrupting tissue using mortar and pestle and
subsequent homogenisation by a rotor-stator homogeni-
zor (Ultra-Turrax T25, Janke & Kunkel IKA-Labortechnik)
in RNA-Bee (Campro Scientific) until uniformly
homogenous (15–45 sec). Total RNA was isolated accord-
ing to manufacturer's instructions followed by purifica-
tion using RN-easy columns (Qiagen). Quality and yield
was determined using Lab-on-a-chip (BioAnalyzer,
Agilent).
Target preparation and hybridisation
Aminoallyl labelled cDNA (aa-cDNA) was prepared based
on a previously described protocol[14]. Aliquots of 1 µg
of total RNA in the presence of 2 µg amino-TN6 primer (5'-
NH2-(CH2)6-TN6, Eurogentec) were adjusted to a volume
of 21 µl with DEPC-treated H2O (diethyl pyrocarbonate,
Sigma), heated for 10 minutes at 70°C and chilled on ice
for 10 minutes. Reverse transcription mastermix (1.8 µl
RevertAid RNaseH-M-MuLV reverse transcriptase (200 U/
µl, MBI Fermentas), 6 µl 5x first-strand buffer (MBI Fer-
mentas), and 1.2 µl 25x aa-dUTP / dNTP solution (2 µl 50
mM dATP, 2 µl 50 mM dCTP, 2 µl 50 mM dGTP, 1.2 µl 50
mM dTTP, 0.8 µl 50 mM aminoallyl-dUTP (Ambion))
was added per reaction and incubated at room tempera-
ture for 10 minutes followed by 2 hours at 42°C. RNA was
hydrolysed by addition of 10 µl 0.5 M EDTA and 10 µl 1
M NaOH and incubation at 65°C for 30 minutes followed
by neutralization by addition of 10 µl 1 M HCl. Ami-
noallyl labelled cDNA was then purified by combining
300 µl of PB-buffer (Qiagen) to 60 µl of the neutralized
sample and centrifuged through a Qiaquick column (Qia-
gen) at 13000 rpm for 1 minute. Two washing steps were
performed by spinning 500 µl of 75% EtOH at 13000 rpm
for 1 minute while discarding the flow-through. To
remove ethanol-traces the columns were centrifuged for
an additional minute. cDNA was recovered by eluting
three times using 30 µl basic H2O (3.3 mM NaHCO3
buffer, pH 9.0) and concentrated to a volume of 6.66 µl
using a speedvac. Aliquots of Cy3 and Cy5 reactive dyes
(PA23001, PA25001, Amersham) were prepared by dis-
solving each vial of monoreactive dye in 40 µl fresh anhy-
drous DMSO (Sigma) and dividing into aliquots of 2 µl
followed by vaccuumdrying until dry and subsequent
storage at 4°C in the presence of silica. Fluorescent dyes
were coupled by adding 3.33 µl of bicarbonate buffer (1
M NaHCO3 buffer, pH 9.0) to the aa-cDNA sample and
dissolving the dried aliquot of reactive dye, followed by
incubation at room temperature for 1 hour in the dark. To
the samples 4.5 µl 4 M hydroxylamine (Sigma) was added
and incubated at room temperature in the dark for 15
minutes, followed by addition of 186 µl TE-3-buffer.
Hybridisation mixtures were prepared by combining a
Cy3-labeled cDNA sample with a Cy5-labeled cDNA sam-
ple and 10 µl Mouse-Hybloc (1 µg/µl, Applied Genetics
Laboratories) followed by removing uncoupled dyes by
spinning through a pre-wetted Microcon column (YM30,
Amicon) for 8 minutes at 13000 rpm. Hybridisation mix-
ture was washed by spinning 500 µl TE-3-buffer through
the column and discarding the flow-through. This step
was repeated two times as 2 µl yeast-tRNA (10 µg/µl,
Sigma) and 2 µl polyA-RNA (10 µg/µl, Sigma) were added
during the last step. Mixture was collected by inverting the
column and spinning for 1 minute at 13000 rpm. Hybrid-
isation mixture was finalized by adding TE-3-buffer to 84
µl together with 17 µl 20x SSC and 3 µl 10% SDS followed
by denaturing at 100°C for 2 minutes, renaturing at room
temperature for 15 minutes and spinning at 13000 rpm
for 10 minutes. Labelled target was hybridised overnight
on murine oligonucleotide microarrays (65-mer with 5'-
hexylaminolinker, Sigma-Genosys mouse 7.5 K oligonu-
cleotide library, spotted in duplicate). Hybridisation
occurred in a automatic hybridisation station (GeneTac,
Perkin Elmer) and was followed by washing with 5xBMC Genomics 2004, 5:57 http://www.biomedcentral.com/1471-2164/5/57
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2xSSC + 0.1% SDS at 30°C, 5x 1xSSC at 30°C, 3x 0.2xSSC
at 30°C, 1x 0.2xSSC at 65°C, 2x 0.2xSSC at 30°C, and
subsequently scanned as described previously[15].
Experimental design, data extraction and analysis
Gene expression profiles from hindlimb muscle derived
from 2 male animals of each strain were generated using
dye-swap experiments. Subsequent duplicate spots on
each array resulted in 8 replicate measurements per gene.
Targets were assigned at random to the arrays, while
avoiding co-hybridisation of samples from the same
strain. GenePix Pro 3.0 (Axon) was used for feature extrac-
tion and quantification. Genes were considered as being
expressed when the corresponding feature was not flagged
by the algorithm provided by GenePix. Local background
corrected spot intensities were normalized using Variance
Stabilization and Normalization (VSN) in R [16]. Array
data has been made available through the GEO data
repository of the National Center for Biotechnology Infor-
mation under series GSE662. Correlation between indi-
viduals was calculated using Pearson's correlation
coefficient. Significantly differential expression levels
were determined using MA-ANOVA (MAANOVA2.0 The
Jackson Laboratory http://www.jax.org/staff/churchill/
labsite/software/anova/), hierarchical t-test [11] and the
False Discovery Rate [17] selection procedure.
Quantitative Reverse Transcription Polymerase Chain 
Reaction
qPCR was performed in duplicate for each individual
resulting in four measurements per strain per gene. cDNA
was prepared by reverse transcription using 1 µg total RNA
as template. Random hexamers (40 ng) were used to
prime the transcription after heating 10 minutes at 70°C
followed by chilling on ice for 10 minutes. cDNA was syn-
thesized by RevertAid RNaseH- MuLV reverse transcriptase
and accompanying buffer (MBI-Fermentas) using 1 mM
dNTPs. The mixture was incubated at room temperature
for 10 minutes before a 2 hour incubation step at 42°C,
followed by 10 minutes at 70°C. Quantitative PCR was
performed using the Lightcycler (Roche). PCR mixture
was prepared by combining cDNA dilution, 10 pmol for-
ward and reverse primer, MgCl2 (4 mM) with 4x home-
made LC mastermix (0.9 mM dNTPs, BSA (1 µl/µl, Phar-
macia Biotech), Taq polymerase (0.8 U/µl), 4x SYBR
Green I (Molecular Probes), 4x AmpliTaq Reaction Buffer
(Perkin Elmer)) to a total volume of 20 µl. Amplicons
were generated during 45 cycles with annealing tempera-
ture set at 55°C. Optimal cDNA dilutions and relative
concentrations were determined using a dilution series
per gene. Replicate experiments (n = 4) were normalized
to 1 and relative expression values were determined by
calculating the ratio per gene over the average relative
expression of genes, which show no differential expres-
sion on both microarray and qPCR (dysferlin, cystatin B,
and thrombospondin 4). Significance levels were calcu-
lated with a one-sample t-test. PCR primer pairs were
designed using the Primer3 search engine, available at:
Primer3 Software Distribution http://frodo.wi.mit.edu/
primer3/primer3_code.html. The screened genes and the
oligonucleotide primer pairs used for each of the genes in
this study correspond to the following nucleotides:
myomesin1, 4761–4780 and 4865–4884 (NM_010867);
tropomodulin1, 670–689 and 878–897 (NM_021883);
dysferlin, 4218–4237 and 4353–4372 (AF188290);
cystatinB, 3–22 and 151–170 (NM_007793);
thrombospondin4, 2167–2186 and 2289–2308
(NM_011582).
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